Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction. [electronic resource]
Producer: 20100806Description: 152-9 p. digitalISSN:- 1558-822X
- Adult
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzamides
- Biomarkers, Tumor -- blood
- Bone Marrow Transplantation -- methods
- Child
- Clinical Trials as Topic
- Combined Modality Therapy
- Disease-Free Survival
- Drug Monitoring
- Drug Resistance, Neoplasm -- genetics
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- blood
- Multicenter Studies as Topic
- Neoplasm, Residual
- Piperazines -- administration & dosage
- Polymerase Chain Reaction -- methods
- Protein Kinase Inhibitors -- administration & dosage
- Pyrimidines -- administration & dosage
- Recurrence
- Sensitivity and Specificity
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.